123987-13-3 Usage
Uses
Used in Pharmaceutical Industry:
3-(4-METHYLPIPERAZIN-1-YL)PHENYL]METHANOL is used as a key intermediate in the synthesis of drugs and biologically active molecules for various therapeutic purposes. Its structural features allow for the development of compounds with specific pharmacological properties, targeting a range of medical conditions.
Used in Medicinal Chemistry Research:
3-(4-METHYLPIPERAZIN-1-YL)PHENYL]METHANOL serves as a building block in medicinal chemistry, aiding researchers in the design and optimization of new drug candidates. Its versatile chemical structure enables the exploration of different chemical modifications to enhance the potency, selectivity, and pharmacokinetic properties of the resulting compounds.
Used in Drug Development:
3-(4-METHYLPIPERAZIN-1-YL)PHENYL]METHANOL is employed in drug development processes to create novel therapeutic agents. Its potential interaction with neurotransmitter receptors suggests applications in the treatment of neurological and psychiatric disorders. Additionally, its use in the synthesis of various drug classes highlights its importance in advancing pharmaceutical innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 123987-13-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,9,8 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 123987-13:
(8*1)+(7*2)+(6*3)+(5*9)+(4*8)+(3*7)+(2*1)+(1*3)=143
143 % 10 = 3
So 123987-13-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H18N2O/c1-13-5-7-14(8-6-13)12-4-2-3-11(9-12)10-15/h2-4,9,15H,5-8,10H2,1H3
123987-13-3Relevant academic research and scientific papers
OXABOROLE ESTERS AND USES THEREOF
-
, (2017/12/05)
The present invention provides oxaborole ester compounds and compositions thereof which are useful to treat diseases associated with parasites, such as Chagas Disease and African Animal Trypanosomosis.
HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE
-
Paragraph 0472, (2014/03/25)
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
